Detalhe da pesquisa
1.
A COVID-19 vaccine candidate based on SARS-CoV-2 spike protein and immune-stimulating complexes.
Appl Microbiol Biotechnol
; 107(11): 3429-3441, 2023 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-37093307
2.
Design and characterization of chimeric Rabies-SARS-CoV-2 virus-like particles for vaccine purposes.
Appl Microbiol Biotechnol
; 107(11): 3495-3508, 2023 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-37126083
3.
Rational design of novel fusion rabies glycoproteins displaying a major antigenic site of foot-and-mouth disease virus for vaccine applications.
Appl Microbiol Biotechnol
; 106(2): 579-592, 2022 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-34971413
4.
Design and optimization of an IgG human ELISA assay reactive to recombinant RBD SARS-CoV-2 protein.
Appl Microbiol Biotechnol
; 106(23): 7933-7948, 2022 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-36329132
5.
Detection and quantification of anti-rabies glycoprotein antibodies: current state and perspectives.
Appl Microbiol Biotechnol
; 105(18): 6547-6557, 2021 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-34448897
6.
Optimization and validation of a blocking ELISA for quantitation of anti-rabies immunoglobulins in multispecies sera.
Appl Microbiol Biotechnol
; 104(9): 4127-4139, 2020 May.
Artigo
Inglês
| MEDLINE | ID: mdl-32170383
7.
Chimeric VLPs Based on HIV-1 Gag and a Fusion Rabies Glycoprotein Induce Specific Antibodies against Rabies and Foot-and-Mouth Disease Virus.
Vaccines (Basel)
; 9(3)2021 Mar 12.
Artigo
Inglês
| MEDLINE | ID: mdl-33809060
8.
A simplified roller bottle platform for the production of a new generation VLPs rabies vaccine for veterinary applications.
Comp Immunol Microbiol Infect Dis
; 65: 70-75, 2019 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-31300130